Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-019658
Filing Date
2020-07-31
Accepted
2020-07-31 16:36:59
Documents
1
Period of Report
2020-07-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 9309
  Complete submission text file 0001213900-20-019658.txt   10715
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Issuer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address
Albanna Rowena (Reporting) CIK: 0001818598 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39336 | Film No.: 201066411